Related Experiment Video
Updated: May 26, 2026

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Published on: May 6, 2019
Extinction of Tumor Antigen Expression by SF2/ASF in JCV-Transformed Cells
Elena Uleri1, Sarah Beltrami, Jennifer Gordon
1Department of Neuroscience, Center for Neurovirology, Temple University School of Medicine, Philadelphia, PA, USA.
Abstract:
The human neurotropic polyomavirus JC (JCV) induces a broad range of neural-origin tumors in experimental animals and has been repeatedly detected in several human cancers, most notably neural crest-origin tumors including medulloblastomas and glioblastomas. The oncogenic activity of JCV is attributed to the viral early gene products, large T and small t antigens, as evident by results from in vitro cell culture and in vivo animal studies. Recently, we have shown that alternative splicing factor, SF2/ASF, has the capacity to exert a negative effect on transcription and splicing of JCV genes in glial cells through direct association with a specific DNA motif within the viral promoter region. Here, we demonstrate that SF2/ASF suppresses large T antigen expression in JCV-transformed tumor cell lines, and the expression of SF2/ASF in such tumor cells thereby inhibits the transforming capacity of the viral tumor antigens. Moreover, down-regulation of SF2/ASF in viral-transformed tumor cell lines induces growth and proliferation of the tumor cells. Mapping analysis of the minimal peptide domain of SF2/ASF responsible for JCV promoter silencing and tumor suppressor activity suggests that amino acid residues 76 to 100 of SF2/ASF are functionally sufficient to suppress the growth of the tumor cells. These observations demonstrate a role for SF2/ASF in JCV-mediated cellular transformation and provide a new avenue of research to pathogenic mechanisms of JCV-induced tumors.
Insights
The splicing factor SF2/ASF suppresses JC virus (JCV) oncogene expression, inhibiting tumor growth. Downregulation of SF2/ASF promotes proliferation in JCV-transformed cells, revealing its tumor suppressor role.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- Human neurotropic polyomavirus JC (JCV) is linked to neural-origin tumors, including medulloblastomas and glioblastomas.
- JCV's oncogenic activity stems from its early gene products, large T and small t antigens.
- The splicing factor SF2/ASF was previously shown to negatively regulate JCV gene transcription and splicing in glial cells.
Purpose of the Study:
- To investigate the role of SF2/ASF in JCV-mediated cellular transformation and tumor development.
- To determine if SF2/ASF expression affects the oncogenic activity of JCV tumor antigens.
- To identify the functional domain of SF2/ASF responsible for its tumor suppressor activity.
Main Methods:
- Assessing SF2/ASF's effect on large T antigen expression in JCV-transformed tumor cell lines.
- Evaluating the impact of SF2/ASF expression levels on tumor cell proliferation and transformation.
- Performing mapping analysis to identify the minimal peptide domain of SF2/ASF involved in JCV promoter silencing and tumor suppression.
Main Results:
- SF2/ASF directly suppresses large T antigen expression in JCV-transformed tumor cells, thereby inhibiting their transforming capacity.
- Down-regulation of SF2/ASF in these cells leads to increased tumor cell growth and proliferation.
- Amino acid residues 76 to 100 of SF2/ASF were identified as the minimal functional domain for suppressing tumor cell growth.
Conclusions:
- SF2/ASF acts as a tumor suppressor by inhibiting JCV's oncogenic activity.
- SF2/ASF plays a critical role in regulating JCV-mediated cellular transformation.
- These findings offer new insights into the pathogenic mechanisms of JCV-induced tumors and potential therapeutic targets.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

